Updated and standardized genome-scale reconstruction of Mycobacterium tuberculosis H37Rv, iEK1011, simulates flux states indicative of physiological conditions
Authors:
Open Access
- 2 March 2018
- journal article
- research article
- Published by Springer Nature in BMC Systems Biology
- Vol. 12 (1) , 1-15
Abstract
The efficacy of antibiotics against M. tuberculosis has been shown to be influenced by experimental media conditions. Investigations of M. tuberculosis growth in physiological conditions have described an environment that is different from common in vitro media. Thus, elucidating the interplay between available nutrient sources and antibiotic efficacy has clear medical relevance. While genome-scale reconstructions of M. tuberculosis have enabled the ability to interrogate media differences for the past 10 years, recent reconstructions have diverged from each other without standardization. A unified reconstruction of M. tuberculosis H37Rv would elucidate the impact of different nutrient conditions on antibiotic efficacy and provide new insights for therapeutic intervention. We present a new genome-scale model of M. tuberculosis H37Rv, named iEK1011, that unifies and updates previous M. tuberculosis H37Rv genome-scale reconstructions. We functionally assess iEK1011 against previous models and show that the model increases correct gene essentiality predictions on two different experimental datasets by 6% (53% to 60%) and 18% (60% to 71%), respectively. We compared simulations between in vitro and approximated in vivo media conditions to examine the predictive capabilities of iEK1011. The simulated differences recapitulated literature defined characteristics in the rewiring of TCA metabolism including succinate secretion, gluconeogenesis, and activation of both the glyoxylate shunt and the methylcitrate cycle. To assist efforts to elucidate mechanisms of antibiotic resistance development, we curated 16 metabolic genes related to antimicrobial resistance and approximated evolutionary drivers of resistance. Comparing simulations of these antibiotic resistance features between in vivo and in vitro media highlighted condition-dependent differences that may influence the efficacy of antibiotics. iEK1011 provides a computational knowledge base for exploring the impact of different environmental conditions on the metabolic state of M. tuberculosis H37Rv. As more experimental data and knowledge of M. tuberculosis H37Rv become available, a unified and standardized M. tuberculosis model will prove to be a valuable resource to the research community studying the systems biology of M. tuberculosis.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (1-UO1-AI124316-01, 1-UO1-AI124316-01, 1-UO1-AI124316-01, 1-UO1-AI124316-01, 1-UO1-AI124316-01, 1-UO1-AI124316-01)
This publication has 69 references indexed in Scilit:
- 13C-Flux Spectral Analysis of Host-Pathogen Metabolism Reveals a Mixed Diet for Intracellular Mycobacterium tuberculosisChemistry & Biology, 2013
- Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontierTrends in Microbiology, 2011
- Discovery and characterization of a unique mycobacterial heme acquisition systemProceedings of the National Academy of Sciences, 2011
- Development and analysis of an in vivo-compatible metabolic network of Mycobacterium tuberculosisBMC Systems Biology, 2010
- Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructionsMolecular Systems Biology, 2010
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyNature Communications, 2010
- Tuberculosis: What We Don’t Know Can, and Does, Hurt UsScience, 2010
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan SynthesisScience, 2009
- Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosisMolecular Microbiology, 2008
- Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ 661 and proposing alternative drug targetsBMC Systems Biology, 2007